Division of Infectious Diseases and Immunology Research | NYU Langone Health

Skip to Main Content

Division of Infectious Diseases and Immunology Research

We focus on research to find new ways to prevent, diagnose, and treat infectious diseases.

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.

Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.

We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.

Core Faculty Investigators

Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies

Ramin Herati, MD
Assistant Professor, Department of Medicine

Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine

Bo Shopsin, MD, PhD
Associate Director, Research, Division of Infectious Diseases
Director, Molecular Epidemiology Director, Antimicrobial-Resistant Pathogens
Program Associate Director of MSTP Curriculum and Programming
Associate Professor, Department of Microbiology

Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine

Faculty Publications

Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.

SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus

Lubkin, Ashira; Bernard-Raichon, Lucie; DuMont, Ashley L; Valero Jimenez, Ana Mayela; Putzel, Gregory G; Gago, Juan; Zwack, Erin E; Olusanya, Olufolakemi; Boguslawski, Kristina M; Dallari, Simone; Dyzenhaus, Sophie; Herrmann, Christin; Ilmain, Juliana K; Isom, Georgia L; Pawline, Miranda; Perault, Andrew I; Perelman, Sofya; Sause, William E; Shahi, Ifrah; St John, Amelia; Tierce, Rebecca; Zheng, Xuhui; Zhou, Chunyi; Noval, Maria G; O'Keeffe, Anna; Podkowik, Magda; Gonzales, Sandra; Inglima, Kenneth; Desvignes, Ludovic; Hochman, Sarah E; Stapleford, Kenneth A; Thorpe, Lorna E; Pironti, Alejandro; Shopsin, Bo; Cadwell, Ken; Dittmann, Meike; Torres, Victor J

mBio. 2024 Aug 14; 15:e0166724

Vaccine Equity: Lessons Learned Exploring Facilitators and Barriers to COVID-19 Vaccination in Urban Black Communities

Parameswaran, Lalitha; Jaysing, Anna; Ding, Helen; Wilkenfeld, Marc; Dean, Ranekka; Wilson, Kesi K; Frank, Olivia; Duerr, Ralf; Mulligan, Mark J

Journal of racial & ethnic health disparities. 2024 Aug ; 11:2109-2119

A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13

Soper, Nathan; Yardumian, Isabelle; Chen, Eric; Yang, Chao; Ciervo, Samantha; Oom, Aaron L; Desvignes, Ludovic; Mulligan, Mark J; Zhang, Yingkai; Lupoli, Tania J

ACS chemical biology. 2024 Jul 19; 19:1593-1603

Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination

Kister, Ilya; Curtin, Ryan; Piquet, Amanda L; Borko, Tyler; Pei, Jinglan; Banbury, Barbara L; Bacon, Tamar E; Kim, Angie; Tuen, Michael; Velmurugu, Yogambigai; Nyovanie, Samantha; Selva, Sean; Samanovic, Marie I; Mulligan, Mark J; Patskovsky, Yury; Priest, Jessica; Cabatingan, Mark; Winger, Ryan C; Krogsgaard, Michelle; Silverman, Gregg J

Annals of clinical & translational neurology. 2024 Jul ; 11:1750-1764

SARS-CoV-2 inflammation durably imprints memory CD4 T cells

Gray-Gaillard, Sophie L; Solis, Sabrina M; Chen, Han M; Monteiro, Clarice; Ciabattoni, Grace; Samanovic, Marie I; Cornelius, Amber R; Williams, Tijaana; Geesey, Emilie; Rodriguez, Miguel; Ortigoza, Mila Brum; Ivanova, Ellie N; Koralov, Sergei B; Mulligan, Mark J; Herati, Ramin Sedaghat

Science immunology. 2024 Jun 21; 9:eadj8526

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults

Rostad, Christina A; Atmar, Robert L; Walter, Emmanuel B; Frey, Sharon; Meier, Jeffery L; Sherman, Amy C; Lai, Lilin; Tsong, Rachel; Kao, Carol M; Raabe, Vanessa; El Sahly, Hana M; Keitel, Wendy A; Whitaker, Jennifer A; Smith, Michael J; Schmader, Kenneth E; Swamy, Geeta K; Abate, Getahun; Winokur, Patricia; Buchanan, Wendy; Cross, Kaitlyn; Wegel, Ashley; Xu, Yongxian; Yildirim, Inci; Kamidani, Satoshi; Rouphael, Nadine; Roberts, Paul C; Mulligan, Mark J; Anderson, Evan J

Clinical infectious diseases. 2024 Jun 14; 78:1757-1768

The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex

Martínez, Jose L; Lemus, Nicholas; Lai, Tsoi Ying; Mishra, Mitali; González-Domínguez, Irene; Puente-Massaguer, Eduard; Loganathan, Madhumathi; Francis, Benjamin; Samanovic, Marie I; Krammer, Florian; Mulligan, Mark J; Simon, Viviana; Palese, Peter; Sun, Weina

Vaccine. 2024 May 22; 42:3365-3373

The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination

Kapadia, Shashi N; Jordan, Ashly E; Eckhardt, Benjamin J; Perlman, David C

Clinical infectious diseases. 2024 May 15; 78:1235-1239